
Mounjaro® for Weight Loss in Munich
Excess weight that affects your health needs a long-term plan. Tirzepatide can support medically supervised weight management.

The information on this page has been medically reviewed by
Spec. Dr. Elizabeta Prendjova Nikolic
Product and Treatment Overview
Mounjaro® contains the prescription-only active ingredient tirzepatide. By acting on GIP and GLP-1 receptors, it affects hunger, fullness and blood glucose regulation, among other functions. For suitable adults, treatment is combined with a diet tailored to their calorie needs and increased physical activity. We decide whether treatment is suitable after an individual medical assessment.

How Treatment Is Administered
After an assessment and guidance on using the medication, the injection is given under the skin once a week. You may briefly feel the fine needle. The dose is adjusted only as prescribed by your doctor. We tailor ongoing care to your progress and how well you tolerate treatment.
Uses
Medication for weight management may be suitable for adults with a BMI of at least 30 kg/m², or at least 27 kg/m² and one or more weight-related conditions. We review previous approaches, existing medical conditions and any reasons to avoid treatment.

Safety
Digestive symptoms are common side effects, particularly at the start or after a dose increase. Your doctor will explain further risks, including pancreatitis, gallbladder problems and dehydration, as well as potential interactions. We discuss pregnancy, breastfeeding and any planned procedures with you before treatment.
Preparation and Aftercare
Please bring information about your weight history, medical conditions and all medications. Tell us about pregnancy plans and any planned procedures or anaesthesia. At your consultation, we explain how to use the medication and what to do if you miss a dose.
Follow your prescribed dosing schedule and attend follow-up appointments. Aim for adequate fluid intake and balanced meals throughout treatment. Please seek prompt medical assessment for persistent vomiting, severe abdominal pain or signs of low blood glucose. Your doctor will help you plan when and how to stop treatment.
The SURMOUNT-4 trial shows that long-term weight maintenance needs its own plan. On average, participants who switched to placebo regained weight, while those who continued treatment maintained their weight loss and lost further weight. Study findings do not predict individual results. At follow-up appointments at DIVINE Medica, we review your weight, health and how well you tolerate treatment. Source: SURMOUNT-4, JAMA 2024

Personal consultation
During your consultation, we assess whether medication-based weight management is appropriate for your health needs. You receive a clear explanation of the benefits, risks and longer-term support. A 30-minute consultation costs From €75 Plus VAT.
Book a consultation >Treatments at a Glance
Frequently
asked
questions ›
Answers to your questions about treatment and what to expect.
After you have been shown how to use the medication, the injection is given under the skin once a week. Your individual dosing schedule takes your progress and how well you tolerate treatment into account. Adjustments are agreed with your doctor.
At follow-up appointments, we review weight changes, how well you tolerate treatment and relevant health markers. We also discuss nutrition, activity and how to preserve muscle to support long-term weight maintenance.